Skip to main content

Table 3 Cox proportional hazards regression analysis for progression free survival on pemetrexed

From: Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Variables Univariate Multivariate
HR (95 % CI) P value HR (95 % CI) P value
EML4-ALK variant 1 0.262 (0.098–0.699) 0.007 0.262 (0.098–0.699) 0.007
EML4-ALK variant 2 2.364 (0.305–18.344) 0.410   
EML4-ALK variant 3a/b 1.366 (0.443–4.214) 0.587   
Non-EML4 variant 2.890 (1.191–7.013) 0.019   
  1. Italic values indicate significance of P value (P < 0.05)
  2. HR hazard ratio; CI confidence interval